Latest Insider Transactions at Exelixis, Inc. (EXEL)
This section provides a real-time view of insider transactions for Exelixis, Inc. (EXEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EXELIXIS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EXELIXIS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 26
2024
|
Jeffrey Hessekiel EVP, General Counsel & Sec |
SELL
Open market or private sale
|
Direct |
20,000
-3.08%
|
$500,000
$25.79 P/Share
|
|
Aug 26
2024
|
Jeffrey Hessekiel EVP, General Counsel & Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.98%
|
$480,000
$24.41 P/Share
|
|
Aug 14
2024
|
Maria C Freire Director |
SELL
Open market or private sale
|
Direct |
8,250
-8.31%
|
$214,500
$26.56 P/Share
|
|
Aug 13
2024
|
Julie Smith Director |
SELL
Other acquisition or disposition
|
Direct |
4,682
-30.28%
|
-
|
|
Aug 12
2024
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Open market or private sale
|
Direct |
20,883
-4.01%
|
$563,841
$27.06 P/Share
|
|
Aug 09
2024
|
Christopher J. Senner EVP and CFO |
SELL
Open market or private sale
|
Direct |
125,000
-14.76%
|
$3,375,000
$27.19 P/Share
|
|
Aug 09
2024
|
Christopher J. Senner EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
125,000
+12.86%
|
$3,000,000
$24.41 P/Share
|
|
Aug 08
2024
|
George Poste Director |
SELL
Open market or private sale
|
Direct |
33,725
-14.49%
|
$876,850
$26.89 P/Share
|
|
Aug 07
2024
|
Jeffrey Hessekiel EVP, General Counsel & Sec |
SELL
Open market or private sale
|
Direct |
80,000
-11.26%
|
$2,000,000
$25.97 P/Share
|
|
Aug 07
2024
|
Jeffrey Hessekiel EVP, General Counsel & Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
80,000
+10.12%
|
$1,920,000
$24.41 P/Share
|
|
Aug 07
2024
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
14,000
-3.94%
|
$350,000
$25.5 P/Share
|
|
Aug 07
2024
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Open market or private sale
|
Direct |
95,000
-15.42%
|
$2,375,000
$25.0 P/Share
|
|
Aug 07
2024
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Exercise of conversion of derivative security
|
Direct |
95,000
+13.36%
|
$2,280,000
$24.41 P/Share
|
|
Jun 04
2024
|
Jack L Wyszomierski Director |
SELL
Open market or private sale
|
Direct |
8,287
-2.32%
|
$182,314
$22.0 P/Share
|
|
May 31
2024
|
Mary C Beckerle Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+35.48%
|
-
|
|
May 31
2024
|
Sue Gail Eckhardt Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+35.48%
|
-
|
|
May 31
2024
|
Jack L Wyszomierski Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+5.0%
|
-
|
|
May 31
2024
|
Bob Oliver Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+33.73%
|
-
|
|
May 31
2024
|
Tomas J. Heyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+33.73%
|
-
|
|
May 31
2024
|
Maria C Freire Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+15.95%
|
-
|
|
May 31
2024
|
George Poste Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+7.49%
|
-
|
|
May 31
2024
|
Stelios Papadopoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+1.45%
|
-
|
|
May 31
2024
|
Julie Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,015
+39.31%
|
-
|
|
May 30
2024
|
David Edward Johnson Director |
BUY
Open market or private purchase
|
Indirect |
225,000
+12.85%
|
$4,500,000
$20.76 P/Share
|
|
May 28
2024
|
David Edward Johnson Director |
BUY
Open market or private purchase
|
Indirect |
200,000
+13.33%
|
$4,000,000
$20.32 P/Share
|
|
May 21
2024
|
Julie Smith Director |
SELL
Open market or private sale
|
Direct |
27,280
-83.36%
|
$572,880
$21.12 P/Share
|
|
May 21
2024
|
George Poste Director |
SELL
Open market or private sale
|
Direct |
11,686
-5.18%
|
$233,720
$20.96 P/Share
|
|
May 21
2024
|
George Poste Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,686
+4.93%
|
$222,034
$19.57 P/Share
|
|
May 20
2024
|
Stelios Papadopoulos Director |
SELL
Open market or private sale
|
Direct |
11,437
-0.9%
|
$240,177
$21.0 P/Share
|
|
May 20
2024
|
Stelios Papadopoulos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,686
+0.91%
|
$222,034
$19.57 P/Share
|
|
May 15
2024
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
30,310
-1.36%
|
$606,200
$20.99 P/Share
|
|
May 15
2024
|
Jeffrey Hessekiel EVP, General Counsel & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
25,941
-1.34%
|
$518,820
$20.99 P/Share
|
|
May 15
2024
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
31,044
-2.07%
|
$620,880
$20.99 P/Share
|
|
May 15
2024
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Payment of exercise price or tax liability
|
Direct |
22,605
-1.41%
|
$452,100
$20.99 P/Share
|
|
May 15
2024
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
73,943
-3.63%
|
$1,478,860
$20.99 P/Share
|
|
May 13
2024
|
Jack L Wyszomierski Director |
SELL
Open market or private sale
|
Direct |
10,923
-3.12%
|
$229,383
$21.37 P/Share
|
|
May 13
2024
|
Jack L Wyszomierski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,686
+3.23%
|
$222,034
$19.57 P/Share
|
|
Mar 21
2024
|
Alan M Garber Director |
SELL
Open market or private sale
|
Direct |
19,205
-34.98%
|
$460,920
$24.01 P/Share
|
|
Mar 21
2024
|
Alan M Garber Director |
BUY
Exercise of conversion of derivative security
|
Direct |
23,491
+29.96%
|
$446,329
$19.57 P/Share
|
|
Feb 23
2024
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
47,020
-10.89%
|
$987,420
$21.45 P/Share
|
|
Feb 23
2024
|
Patrick J. Haley EVP, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
63,350
+12.79%
|
-
|
|
Feb 23
2024
|
Jeffrey Hessekiel EVP, General Counsel & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
63,350
+8.82%
|
-
|
|
Feb 23
2024
|
Christopher J. Senner EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
82,121
+9.85%
|
-
|
|
Feb 23
2024
|
Michael Morrissey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
241,670
+18.88%
|
-
|
|
Feb 23
2024
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Grant, award, or other acquisition
|
Direct |
63,350
+10.46%
|
-
|
|
Feb 23
2024
|
Amy C. Peterson EVP Prod Dev & Med Aff & CMO |
BUY
Grant, award, or other acquisition
|
Direct |
82,121
+20.31%
|
-
|
|
Feb 21
2024
|
David Edward Johnson Director |
BUY
Open market or private purchase
|
Indirect |
190,000
+14.72%
|
$3,800,000
$20.7 P/Share
|
|
Feb 15
2024
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Payment of exercise price or tax liability
|
Direct |
10,630
-2.17%
|
$212,600
$20.39 P/Share
|
|
Jan 11
2024
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Payment of exercise price or tax liability
|
Direct |
11,606
-2.32%
|
$255,332
$22.86 P/Share
|
|
Jan 11
2024
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Grant, award, or other acquisition
|
Direct |
63,224
+11.2%
|
-
|